Colorectal Cancer Clinical Trials in Dallas

Showing 221-240 of 291 trials

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

NCT01490866

This is a non-randomized, open-label, Phase II trial investigating axitinib as a single-agent maintenance therapy following standard first-line FOLFOX/bevacizumab therapy for patients with mCRC.

Colorectal Cancer

SCRI Development Innovations, LLC70 participantsStarted Jan 2012

Jonesboro, Arkansas, United States • Fort Myers, Florida, United States • Pensacola, Florida, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

NCT00252564

The purpose of this study is to compare the rates of Progression-Free Survival (PFS) at 12 months for patients treated with Bev-FOLFOX versus patients treated with FOLF-CB for first line treatment of metastatic colorectal cancer.

Metastatic Colorectal Cancer

US Oncology Research247 participantsStarted Sep 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sedona, Arizona, United States +79 more locations

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps

Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Study of Ruxolitinib in Colorectal Cancer Patients

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer

Vitamin D/Calcium Polyp Prevention Study

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Sym004 in Patients With Advanced Solid Tumors

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Other Conditions in Dallas